Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Bullboard Posts
Comment by canyousayon Jan 11, 2016 11:03pm
98 Views
Post# 24448642

RE:RE:RE:RE:RE:RE:RE:RE:Someone Needs To Read The Balance Sheet

RE:RE:RE:RE:RE:RE:RE:RE:Someone Needs To Read The Balance SheetUnfortunately there are issues and they need stuff to happen faster. In general, I find any categorization of companies with less than $10 million in revenues as global leaders comical. I can't think of an industry where $10 million makes you a global leader. For investors, the only global leadership that matters is revenues. Right now it is a challenge to even pull positive cashflow from current business. Time to focus on areas where the odds are in their favor.
Bullboard Posts